GS24-B057

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameGS24-B057
Drug Alias NameGS24-B057GS24B057
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionDNA topoisomerase I inhibitorsAnti-NECTIN4Anti-Trop-2
TargetsTumor-associated calcium signal transducer 2Nectin-4DNA topoisomerase I
Therapy Area/IndicationsTriple Negative Breast NeoplasmsCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsCarcinoma, Transitional Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A